Healthcare Blog

FEBRUARY 15, 2023

Beckman Coulter sponsored session) March 7 – Give Blood Culture Quality the Attention Your Patients Deserve – It Takes a Team! (BD BD Sponsored Session) March 9 – Recognition and Treatment of Infections in ESKD and AKI in Sepsis – A Special World Kidney Day Event (1.20

Health Outcomes 40

Health Outcomes Hospitals 40

McGuire Wood

JUNE 6, 2023

One of the things I greatly appreciated about the HVP team, starting with our private equity sponsor Assured Healthcare Partners, was the intent, interest and commitment to build something for long-term intrinsic value. BD: It’s a huge market. BD: As a baseball fan, I’d say we’re in the second or third inning of the cycle.

Hospitals 52

Hospitals Medicare Medicare 52

HIT Consultant

FEBRUARY 7, 2024

Inpatient Clinical Care 340B Management Systems: Verity Solutions Verity 340B Acute Care EHR (Large – Over 400 Beds): Epic EpicCare Inpatient HER Acute Care EHR (Medium – 151-400 Beds): Epic EpicCare Inpatient HER Acute Care EHR (Small – 1-150 Beds): MEDITECH Expanse Acute Care Automated Dispensing Cabinets: BD Pyxis MedStation ES (..)

Nurses 105

Nurses Governance Compliance Hospitals 105

HIT Consultant

FEBRUARY 9, 2023

Best in KLAS: Inpatient Clinical Care 340B Management Systems PharmaForce 340B Acute Care EMR: Large ( >400 Beds) Epic EpicCare Inpatient EMR Acute Care EMR: Midsize (151–400 Beds) Epic EpicCare Inpatient EMR Acute Care EMR: Small (1–150 Beds) MEDITECH Expanse Acute Care EMR Automated Dispensing Cabinets BD Pyxis MedStation ES Clinical Communications: (..)

Nurses 52

Nurses Compliance Hospitals 52

SQA

JUNE 10, 2021

Recall of BD Venflon Pro Safety and Venflon Pro IV Cannula, 04 May 2021. Becton Dickinson (BD) is recalling all ethylene oxide (EtO) sterilized BD Venflon Pro Safety (VPS) and Venflon Pro IV Cannula after identifying an increase in reports of leakage from the injection port.

FDA 52

FDA COVID-19 COVID-19 Vaccine Compliance 52

HIT Consultant

FEBRUARY 19, 2023

Symptomatic adverse events To mitigate patient burden, sponsors should define a concise set of the most relevant symptomatic adverse events likely to occur and capture PRO data in both treatment and control arms. Sponsors can proactively address this challenge by creating assessment windows that afford patients ample time for completion.

FDA 98

FDA COVID-19 Telemedicine 98

SQA

SEPTEMBER 2, 2022

BD Announces Voluntary Recall on Intraosseous Products, 22 June 2022. BD (Becton, Dickinson and Company), a leading global medical technology company, announced a voluntary recall on the BD Intraosseous Needle Set Kits, BD Intraosseous Manual Driver Kits and BD Intraosseous Powered Drivers.

FDA 91

FDA COVID-19 Nursing Homes Compliance 91